Rank | Gene Set | Z-score |
---|---|---|
1 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.46611820 |
2 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.46611820 |
3 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 6.18790952 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.12573060 |
5 | negative regulation of cell killing (GO:0031342) | 5.12573060 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97819719 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62469446 |
8 | response to type I interferon (GO:0034340) | 4.42708561 |
9 | cellular response to type I interferon (GO:0071357) | 4.41068238 |
10 | type I interferon signaling pathway (GO:0060337) | 4.41068238 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.14566956 |
12 | positive regulation of antigen processing and presentation (GO:0002579) | 4.05552586 |
13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97922617 |
14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97922617 |
15 | modulation by symbiont of host immune response (GO:0052553) | 3.97922617 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97922617 |
17 | modulation by symbiont of host defense response (GO:0052031) | 3.97922617 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97922617 |
19 | regulation of interferon-alpha production (GO:0032647) | 3.95814137 |
20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.84307889 |
21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.83393923 |
22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.80698460 |
23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.72183942 |
24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.67094082 |
25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.65661367 |
26 | immunoglobulin mediated immune response (GO:0016064) | 3.65488197 |
27 | cellular response to interleukin-15 (GO:0071350) | 3.64246105 |
28 | lymphocyte chemotaxis (GO:0048247) | 3.58568911 |
29 | regulation of antigen processing and presentation (GO:0002577) | 3.57627429 |
30 | detection of bacterium (GO:0016045) | 3.56552014 |
31 | neutrophil activation involved in immune response (GO:0002283) | 3.52789559 |
32 | NIK/NF-kappaB signaling (GO:0038061) | 3.51705523 |
33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.47229920 |
34 | detection of other organism (GO:0098543) | 3.46680624 |
35 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.42607131 |
36 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.40761989 |
37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37201257 |
38 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.35156925 |
39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34570862 |
40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.32470563 |
41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29410964 |
42 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.29106319 |
43 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.29106319 |
44 | response to peptidoglycan (GO:0032494) | 3.28438012 |
45 | lymphocyte migration (GO:0072676) | 3.27963889 |
46 | cellular response to interferon-beta (GO:0035458) | 3.26152889 |
47 | response to muramyl dipeptide (GO:0032495) | 3.26123964 |
48 | response to interferon-beta (GO:0035456) | 3.19333819 |
49 | respiratory burst (GO:0045730) | 3.18792361 |
50 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18457033 |
51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17484169 |
52 | tolerance induction (GO:0002507) | 3.15520239 |
53 | response to interferon-alpha (GO:0035455) | 3.14265187 |
54 | myeloid dendritic cell differentiation (GO:0043011) | 3.10296683 |
55 | T cell migration (GO:0072678) | 3.08489413 |
56 | macrophage activation involved in immune response (GO:0002281) | 3.06261198 |
57 | negative thymic T cell selection (GO:0045060) | 3.03802314 |
58 | myeloid dendritic cell activation (GO:0001773) | 3.01906558 |
59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01755717 |
60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.98672780 |
61 | positive regulation of interferon-beta production (GO:0032728) | 2.97349483 |
62 | cellular response to zinc ion (GO:0071294) | 2.97274210 |
63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97138296 |
64 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.95250150 |
65 | regulation of response to interferon-gamma (GO:0060330) | 2.95050789 |
66 | negative T cell selection (GO:0043383) | 2.93722456 |
67 | leukocyte aggregation (GO:0070486) | 2.92506987 |
68 | detection of external biotic stimulus (GO:0098581) | 2.91632300 |
69 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91298909 |
70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91159985 |
71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90634182 |
72 | regulation of T cell tolerance induction (GO:0002664) | 2.89754905 |
73 | T-helper 1 type immune response (GO:0042088) | 2.89116749 |
74 | positive regulation of interleukin-12 production (GO:0032735) | 2.88639587 |
75 | positive thymic T cell selection (GO:0045059) | 2.87733314 |
76 | negative regulation of viral genome replication (GO:0045071) | 2.87221097 |
77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86933872 |
78 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85621096 |
79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85168367 |
80 | maturation of SSU-rRNA (GO:0030490) | 2.84345828 |
81 | defense response to protozoan (GO:0042832) | 2.84300353 |
82 | neutrophil activation (GO:0042119) | 2.83456716 |
83 | positive regulation of B cell differentiation (GO:0045579) | 2.83274040 |
84 | response to host immune response (GO:0052572) | 2.83118647 |
85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83118647 |
86 | cellular response to interferon-gamma (GO:0071346) | 2.82542241 |
87 | negative regulation of innate immune response (GO:0045824) | 2.82268675 |
88 | granulocyte activation (GO:0036230) | 2.80948339 |
89 | B cell mediated immunity (GO:0019724) | 2.79265914 |
90 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.75918414 |
91 | response to protozoan (GO:0001562) | 2.74035875 |
92 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.73599417 |
93 | regulation of B cell differentiation (GO:0045577) | 2.73403286 |
94 | regulation of RIG-I signaling pathway (GO:0039535) | 2.71403212 |
95 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.70730032 |
96 | regulation of cell killing (GO:0031341) | 2.70729566 |
97 | regulation of cholesterol storage (GO:0010885) | 2.69405169 |
98 | positive regulation of cell killing (GO:0031343) | 2.69366771 |
99 | mast cell activation (GO:0045576) | 2.68012778 |
100 | positive regulation of humoral immune response (GO:0002922) | 2.66078313 |
101 | dendritic cell differentiation (GO:0097028) | 2.65975721 |
102 | leukocyte cell-cell adhesion (GO:0007159) | 2.65057796 |
103 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62644918 |
104 | response to host (GO:0075136) | 2.62644918 |
105 | response to host defenses (GO:0052200) | 2.62644918 |
106 | cellular response to virus (GO:0098586) | 2.62321619 |
107 | regulation of interleukin-12 production (GO:0032655) | 2.61623923 |
108 | natural killer cell mediated immunity (GO:0002228) | 2.61387018 |
109 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.61387018 |
110 | response to interferon-gamma (GO:0034341) | 2.61106361 |
111 | cellular response to exogenous dsRNA (GO:0071360) | 2.59570535 |
112 | low-density lipoprotein particle clearance (GO:0034383) | 2.55826113 |
113 | thymic T cell selection (GO:0045061) | 2.54687563 |
114 | cellular extravasation (GO:0045123) | 2.54086381 |
115 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.53837861 |
116 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.53646983 |
117 | detection of biotic stimulus (GO:0009595) | 2.53519478 |
118 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.53095742 |
119 | T cell costimulation (GO:0031295) | 2.52861163 |
120 | I-kappaB phosphorylation (GO:0007252) | 2.52266511 |
121 | regulation of natural killer cell differentiation (GO:0032823) | 2.51262373 |
122 | myeloid cell activation involved in immune response (GO:0002275) | 2.50792858 |
123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.50411347 |
124 | diol metabolic process (GO:0034311) | 2.50264391 |
125 | lymphocyte costimulation (GO:0031294) | 2.49420331 |
126 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.49223123 |
127 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.49205531 |
128 | positive regulation of B cell mediated immunity (GO:0002714) | 2.49205531 |
129 | negative regulation of phagocytosis (GO:0050765) | 2.48899160 |
130 | negative regulation of interleukin-12 production (GO:0032695) | 2.48639526 |
131 | JAK-STAT cascade (GO:0007259) | 2.48155287 |
132 | positive regulation of defense response to virus by host (GO:0002230) | 2.47140761 |
133 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.47130011 |
134 | negative regulation of stress fiber assembly (GO:0051497) | 2.46946310 |
135 | T cell selection (GO:0045058) | 2.46788049 |
136 | response to interleukin-15 (GO:0070672) | 2.44909204 |
137 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.44791899 |
138 | natural killer cell differentiation (GO:0001779) | 2.44160094 |
139 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.42960736 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.20388021 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.71968928 |
3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.34271447 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.07087697 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.04697210 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.54353728 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.25770106 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15038827 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99687645 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91873481 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91352436 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63732566 |
13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.62308740 |
14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.61922668 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60641620 |
16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58640640 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50558988 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.48637833 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43601241 |
20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.24342478 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17369334 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.10998532 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10078647 |
24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.08438055 |
25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01715858 |
26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00951193 |
27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96893807 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93595673 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91039275 |
30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89044558 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87653212 |
32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81746468 |
33 | MYB_26560356_Chip-Seq_TH1_Human | 1.78453542 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75880885 |
35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74284563 |
36 | MYC_22102868_ChIP-Seq_BL_Human | 1.72820474 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67714722 |
38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65867754 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59829656 |
40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.59520348 |
41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59489346 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58712498 |
43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51345311 |
44 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48768088 |
45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48605003 |
46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44805364 |
47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41828687 |
48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41585182 |
49 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39691838 |
50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39227399 |
51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38663325 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37899758 |
53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37528569 |
54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37232159 |
55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35949106 |
56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35510644 |
57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35321809 |
58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32005952 |
59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27047219 |
60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25202839 |
61 | MAF_26560356_Chip-Seq_TH2_Human | 1.24703591 |
62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22120832 |
63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21909001 |
64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21536119 |
65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21384132 |
66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19912063 |
67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16732616 |
68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15210643 |
69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14922518 |
70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14765812 |
71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13412025 |
72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12761246 |
73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11233275 |
74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10678763 |
75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10649671 |
76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10572123 |
77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10021162 |
78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09903707 |
79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09545968 |
80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09466375 |
81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08749831 |
82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08069654 |
83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06800362 |
84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06411384 |
85 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05895093 |
86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05843888 |
87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05355596 |
88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03873443 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02886955 |
90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00990460 |
91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99218930 |
92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98767696 |
93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97485136 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97370028 |
95 | P300_27268052_Chip-Seq_Bcells_Human | 0.97173248 |
96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96101605 |
97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95952188 |
98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95864764 |
99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93685315 |
100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92447938 |
101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91834319 |
102 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91449295 |
103 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90747247 |
104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90631562 |
105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90358775 |
106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89849754 |
107 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89613981 |
108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87488276 |
109 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.86250648 |
110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86113400 |
111 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86071749 |
112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85801267 |
113 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85077566 |
114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84709576 |
115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82321572 |
116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82131308 |
117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82023692 |
118 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81956737 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 4.04197859 |
2 | MP0000685_abnormal_immune_system | 3.22981671 |
3 | MP0009785_altered_susceptibility_to | 3.15058839 |
4 | MP0003436_decreased_susceptibility_to | 3.04926355 |
5 | MP0005387_immune_system_phenotype | 2.96674160 |
6 | MP0001790_abnormal_immune_system | 2.96674160 |
7 | MP0003724_increased_susceptibility_to | 2.78780715 |
8 | MP0005671_abnormal_response_to | 2.74926211 |
9 | MP0005000_abnormal_immune_tolerance | 2.66385482 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.62318738 |
11 | MP0005025_abnormal_response_to | 2.60980803 |
12 | MP0003303_peritoneal_inflammation | 2.53350209 |
13 | MP0006082_CNS_inflammation | 2.50380094 |
14 | MP0001800_abnormal_humoral_immune | 2.48741635 |
15 | MP0002419_abnormal_innate_immunity | 2.43545375 |
16 | * MP0002452_abnormal_antigen_presenting | 2.35784357 |
17 | MP0002166_altered_tumor_susceptibility | 2.34912641 |
18 | MP0002723_abnormal_immune_serum | 2.27130784 |
19 | MP0003300_gastrointestinal_ulcer | 2.25405640 |
20 | MP0004510_myositis | 2.22710120 |
21 | MP0005058_abnormal_lysosome_morphology | 2.17216052 |
22 | MP0003195_calcinosis | 2.16064950 |
23 | * MP0001819_abnormal_immune_cell | 2.11794476 |
24 | * MP0002420_abnormal_adaptive_immunity | 2.10339569 |
25 | MP0004947_skin_inflammation | 2.08334994 |
26 | MP0002006_tumorigenesis | 1.94643079 |
27 | MP0003763_abnormal_thymus_physiology | 1.90102686 |
28 | MP0003191_abnormal_cellular_cholesterol | 1.87151828 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.85748330 |
30 | MP0001533_abnormal_skeleton_physiology | 1.83490266 |
31 | MP0005464_abnormal_platelet_physiology | 1.83163551 |
32 | MP0010155_abnormal_intestine_physiology | 1.83150546 |
33 | MP0002405_respiratory_system_inflammati | 1.80741785 |
34 | MP0001853_heart_inflammation | 1.78918894 |
35 | MP0001845_abnormal_inflammatory_respons | 1.76492351 |
36 | MP0009840_abnormal_foam_cell | 1.73781249 |
37 | MP0002254_reproductive_system_inflammat | 1.71058944 |
38 | MP0005310_abnormal_salivary_gland | 1.66965014 |
39 | * MP0000716_abnormal_immune_system | 1.64297792 |
40 | * MP0002398_abnormal_bone_marrow | 1.59551606 |
41 | MP0003806_abnormal_nucleotide_metabolis | 1.58207618 |
42 | MP0008469_abnormal_protein_level | 1.54792121 |
43 | MP0001873_stomach_inflammation | 1.54128426 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.52597655 |
45 | MP0005360_urolithiasis | 1.46873555 |
46 | MP0003448_altered_tumor_morphology | 1.44172649 |
47 | MP0003172_abnormal_lysosome_physiology | 1.37643077 |
48 | MP0000689_abnormal_spleen_morphology | 1.36198491 |
49 | MP0009764_decreased_sensitivity_to | 1.35096173 |
50 | MP0009278_abnormal_bone_marrow | 1.34073805 |
51 | MP0002933_joint_inflammation | 1.33521085 |
52 | * MP0002429_abnormal_blood_cell | 1.33273633 |
53 | MP0000858_altered_metastatic_potential | 1.30781366 |
54 | MP0000343_altered_response_to | 1.30620583 |
55 | MP0002722_abnormal_immune_system | 1.29485381 |
56 | MP0003252_abnormal_bile_duct | 1.24645083 |
57 | MP0005397_hematopoietic_system_phenotyp | 1.24503186 |
58 | MP0001545_abnormal_hematopoietic_system | 1.24503186 |
59 | MP0002139_abnormal_hepatobiliary_system | 1.24047794 |
60 | MP0008438_abnormal_cutaneous_collagen | 1.19957748 |
61 | MP0003866_abnormal_defecation | 1.18224228 |
62 | MP0002998_abnormal_bone_remodeling | 1.17249152 |
63 | MP0003566_abnormal_cell_adhesion | 1.14874085 |
64 | MP0003183_abnormal_peptide_metabolism | 1.10942346 |
65 | MP0002877_abnormal_melanocyte_morpholog | 1.10706539 |
66 | MP0004782_abnormal_surfactant_physiolog | 1.07843374 |
67 | MP0003075_altered_response_to | 1.03277926 |
68 | MP0003045_fibrosis | 1.03152096 |
69 | MP0003705_abnormal_hypodermis_morpholog | 0.99842416 |
70 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99498756 |
71 | MP0001851_eye_inflammation | 0.98634889 |
72 | MP0000465_gastrointestinal_hemorrhage | 0.97969910 |
73 | MP0010352_gastrointestinal_tract_polyps | 0.97661881 |
74 | MP0001986_abnormal_taste_sensitivity | 0.96490163 |
75 | MP0005023_abnormal_wound_healing | 0.95735386 |
76 | MP0006054_spinal_hemorrhage | 0.94817435 |
77 | MP0003453_abnormal_keratinocyte_physiol | 0.94262976 |
78 | MP0000604_amyloidosis | 0.93729503 |
79 | MP0010234_abnormal_vibrissa_follicle | 0.93675895 |
80 | MP0004381_abnormal_hair_follicle | 0.93283069 |
81 | MP0009763_increased_sensitivity_to | 0.92433263 |
82 | MP0004808_abnormal_hematopoietic_stem | 0.91253467 |
83 | MP0002396_abnormal_hematopoietic_system | 0.90855534 |
84 | MP0002277_abnormal_respiratory_mucosa | 0.90116708 |
85 | MP0005076_abnormal_cell_differentiation | 0.89501532 |
86 | MP0000703_abnormal_thymus_morphology | 0.88014797 |
87 | MP0005390_skeleton_phenotype | 0.87861331 |
88 | MP0000609_abnormal_liver_physiology | 0.87740666 |
89 | MP0000249_abnormal_blood_vessel | 0.85967387 |
90 | MP0002136_abnormal_kidney_physiology | 0.84257889 |
91 | MP0005075_abnormal_melanosome_morpholog | 0.84210042 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 0.84137516 |
93 | MP0010307_abnormal_tumor_latency | 0.83411376 |
94 | MP0009643_abnormal_urine_homeostasis | 0.82325743 |
95 | MP0005365_abnormal_bile_salt | 0.80875270 |
96 | MP0001958_emphysema | 0.79985927 |
97 | MP0001879_abnormal_lymphatic_vessel | 0.78917404 |
98 | MP0003091_abnormal_cell_migration | 0.77906236 |
99 | MP0005166_decreased_susceptibility_to | 0.77420145 |
100 | MP0010329_abnormal_lipoprotein_level | 0.77086534 |
101 | MP0003186_abnormal_redox_activity | 0.75244838 |
102 | MP0001348_abnormal_lacrimal_gland | 0.75165678 |
103 | MP0002693_abnormal_pancreas_physiology | 0.74627469 |
104 | MP0002876_abnormal_thyroid_physiology | 0.74411008 |
105 | MP0004147_increased_porphyrin_level | 0.74321034 |
106 | MP0003795_abnormal_bone_structure | 0.71363129 |
107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70817781 |
108 | MP0000490_abnormal_crypts_of | 0.68987237 |
109 | MP0005164_abnormal_response_to | 0.67913625 |
110 | MP0005165_increased_susceptibility_to | 0.67256936 |
111 | MP0000613_abnormal_salivary_gland | 0.66568936 |
112 | MP0001881_abnormal_mammary_gland | 0.66325183 |
113 | MP0003828_pulmonary_edema | 0.65805006 |
114 | MP0002163_abnormal_gland_morphology | 0.65096078 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.64893439 |
116 | MP0002132_abnormal_respiratory_system | 0.64114355 |
117 | MP0001765_abnormal_ion_homeostasis | 0.63946263 |
118 | MP0005319_abnormal_enzyme/_coenzyme | 0.61516603 |
119 | MP0005275_abnormal_skin_tensile | 0.60196847 |
120 | MP0001663_abnormal_digestive_system | 0.58783997 |
121 | MP0003279_aneurysm | 0.58426099 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.37625019 |
2 | Recurrent abscess formation (HP:0002722) | 4.85672764 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.66585654 |
4 | Hypothermia (HP:0002045) | 4.60547091 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.37841520 |
6 | Myositis (HP:0100614) | 4.08483830 |
7 | Autoimmune thrombocytopenia (HP:0001973) | 3.95652033 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.93040271 |
9 | Recurrent fungal infections (HP:0002841) | 3.72803886 |
10 | Vacuolated lymphocytes (HP:0001922) | 3.71133056 |
11 | Abnormality of macrophages (HP:0004311) | 3.69339811 |
12 | Interstitial pulmonary disease (HP:0006530) | 3.64618847 |
13 | Recurrent viral infections (HP:0004429) | 3.54968206 |
14 | Orchitis (HP:0100796) | 3.54791224 |
15 | Systemic lupus erythematosus (HP:0002725) | 3.54637223 |
16 | * Abnormality of the nasal mucosa (HP:0000433) | 3.29013083 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.22413827 |
18 | Recurrent skin infections (HP:0001581) | 3.21682276 |
19 | * Nasal polyposis (HP:0100582) | 3.20599457 |
20 | * Chronic otitis media (HP:0000389) | 3.19342419 |
21 | Increased cerebral lipofuscin (HP:0011813) | 3.18836203 |
22 | Vasculitis (HP:0002633) | 3.14255270 |
23 | Dysostosis multiplex (HP:0000943) | 3.08745999 |
24 | Pustule (HP:0200039) | 3.07527004 |
25 | Optic neuritis (HP:0100653) | 3.00924966 |
26 | Retrobulbar optic neuritis (HP:0100654) | 3.00924966 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00068432 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00068432 |
29 | Premature loss of primary teeth (HP:0006323) | 2.99835540 |
30 | Spontaneous hematomas (HP:0007420) | 2.99365914 |
31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99182131 |
32 | * Recurrent bronchitis (HP:0002837) | 2.97963496 |
33 | Hematochezia (HP:0002573) | 2.88721026 |
34 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86388564 |
35 | Mucopolysacchariduria (HP:0008155) | 2.86388564 |
36 | Gingivitis (HP:0000230) | 2.85192957 |
37 | Colitis (HP:0002583) | 2.82966827 |
38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.81420395 |
39 | Cellulitis (HP:0100658) | 2.77947337 |
40 | Encephalitis (HP:0002383) | 2.75368019 |
41 | Inflammation of the large intestine (HP:0002037) | 2.74470769 |
42 | Increased IgE level (HP:0003212) | 2.73108646 |
43 | Hypergammaglobulinemia (HP:0010702) | 2.69956388 |
44 | Abnormality of T cell number (HP:0011839) | 2.68856470 |
45 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66024287 |
46 | Gastrointestinal inflammation (HP:0004386) | 2.65770029 |
47 | Periodontitis (HP:0000704) | 2.63411628 |
48 | Stomatitis (HP:0010280) | 2.61664453 |
49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61373909 |
50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61373909 |
51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61373909 |
52 | Abnormality of T cell physiology (HP:0011840) | 2.58381048 |
53 | Meningitis (HP:0001287) | 2.57103348 |
54 | Myocardial infarction (HP:0001658) | 2.57021024 |
55 | Increased IgM level (HP:0003496) | 2.56960304 |
56 | Pulmonary infiltrates (HP:0002113) | 2.56439170 |
57 | Abnormality of T cells (HP:0002843) | 2.55386204 |
58 | Loss of speech (HP:0002371) | 2.54110001 |
59 | Arterial thrombosis (HP:0004420) | 2.53159245 |
60 | T lymphocytopenia (HP:0005403) | 2.48987639 |
61 | Thick nail (HP:0001805) | 2.48202324 |
62 | Gastrointestinal infarctions (HP:0005244) | 2.47562558 |
63 | IgM deficiency (HP:0002850) | 2.46466627 |
64 | Thrombocytosis (HP:0001894) | 2.46442742 |
65 | Autoimmune hemolytic anemia (HP:0001890) | 2.45220119 |
66 | Basal ganglia calcification (HP:0002135) | 2.43695372 |
67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43249835 |
68 | Obstructive lung disease (HP:0006536) | 2.43249835 |
69 | Hemoptysis (HP:0002105) | 2.41046539 |
70 | Alveolar cell carcinoma (HP:0006519) | 2.40117162 |
71 | Global brain atrophy (HP:0002283) | 2.34332376 |
72 | Gingival bleeding (HP:0000225) | 2.30406015 |
73 | Agammaglobulinemia (HP:0004432) | 2.29513720 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28214166 |
75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28214166 |
76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28214166 |
77 | Leukocytosis (HP:0001974) | 2.27239243 |
78 | Osteomyelitis (HP:0002754) | 2.25798429 |
79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.24446270 |
80 | Petechiae (HP:0000967) | 2.24296947 |
81 | Enlarged epiphyses (HP:0010580) | 2.24146747 |
82 | Urticaria (HP:0001025) | 2.23339377 |
83 | Glomerulonephritis (HP:0000099) | 2.19851719 |
84 | IgG deficiency (HP:0004315) | 2.19752384 |
85 | Tetraparesis (HP:0002273) | 2.17580684 |
86 | Increased serum ferritin (HP:0003281) | 2.16474862 |
87 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.15352825 |
88 | Joint swelling (HP:0001386) | 2.15214079 |
89 | Eosinophilia (HP:0001880) | 2.13962736 |
90 | Keratoconjunctivitis sicca (HP:0001097) | 2.13281868 |
91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11514537 |
92 | Prolonged bleeding time (HP:0003010) | 2.11385770 |
93 | Osteolytic defects of the hand bones (HP:0009699) | 2.10404377 |
94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10404377 |
95 | Lymphopenia (HP:0001888) | 2.10217803 |
96 | Vascular calcification (HP:0004934) | 2.10213283 |
97 | Keratoconjunctivitis (HP:0001096) | 2.09964071 |
98 | Abnormality of eosinophils (HP:0001879) | 2.08789253 |
99 | Nephritis (HP:0000123) | 2.07767601 |
100 | * Emphysema (HP:0002097) | 2.04829734 |
101 | Chronic diarrhea (HP:0002028) | 2.03995259 |
102 | Gastrointestinal stroma tumor (HP:0100723) | 2.02016539 |
103 | Epistaxis (HP:0000421) | 2.01526848 |
104 | Skin rash (HP:0000988) | 2.01441312 |
105 | Anorexia (HP:0002039) | 2.00935884 |
106 | Cheilitis (HP:0100825) | 2.00694905 |
107 | Panhypogammaglobulinemia (HP:0003139) | 2.00569836 |
108 | Increased CSF protein (HP:0002922) | 2.00017414 |
109 | Esophageal varix (HP:0002040) | 1.99869220 |
110 | * Skin ulcer (HP:0200042) | 1.99276276 |
111 | Vertebral compression fractures (HP:0002953) | 1.99094586 |
112 | Granulocytopenia (HP:0001913) | 1.95685210 |
113 | Acne (HP:0001061) | 1.95615717 |
114 | Abnormality of iron homeostasis (HP:0011031) | 1.95225301 |
115 | Peritonitis (HP:0002586) | 1.94393880 |
116 | Hypoproteinemia (HP:0003075) | 1.94151706 |
117 | Pulmonary embolism (HP:0002204) | 1.93958850 |
118 | Arthralgia (HP:0002829) | 1.93585986 |
119 | Polycythemia (HP:0001901) | 1.93483521 |
120 | Abnormality of the pleura (HP:0002103) | 1.93292045 |
121 | Purpura (HP:0000979) | 1.92335392 |
122 | IgA deficiency (HP:0002720) | 1.90864918 |
123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84767936 |
124 | Chest pain (HP:0100749) | 1.84733983 |
125 | Complement deficiency (HP:0004431) | 1.83584844 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TYK2 | 3.52392550 |
2 | MAP4K1 | 3.48238727 |
3 | TLK1 | 3.46434621 |
4 | MAP3K14 | 3.38985204 |
5 | TBK1 | 3.29287780 |
6 | ERN1 | 3.23283363 |
7 | JAK3 | 3.20007450 |
8 | IKBKE | 2.88913430 |
9 | ARAF | 2.65666457 |
10 | BMPR2 | 2.63376340 |
11 | FGFR4 | 2.58939507 |
12 | BLK | 2.49939218 |
13 | JAK1 | 2.36828593 |
14 | KIT | 2.29480022 |
15 | IRAK4 | 2.16435209 |
16 | ZAP70 | 2.06529496 |
17 | TRIB3 | 1.95000374 |
18 | TGFBR2 | 1.94575123 |
19 | IRAK3 | 1.94513021 |
20 | TXK | 1.94401392 |
21 | IKBKB | 1.92867445 |
22 | MAP3K9 | 1.89140390 |
23 | EPHB1 | 1.88982326 |
24 | FGFR3 | 1.64135312 |
25 | STK10 | 1.59299931 |
26 | CSK | 1.54732944 |
27 | EPHA3 | 1.47263813 |
28 | NME2 | 1.45259657 |
29 | TAOK3 | 1.44617002 |
30 | KDR | 1.44221407 |
31 | CHUK | 1.42087517 |
32 | MAP3K13 | 1.38921684 |
33 | BTK | 1.38445561 |
34 | MOS | 1.37066671 |
35 | FLT3 | 1.36879269 |
36 | LRRK2 | 1.29585644 |
37 | PIM2 | 1.29490391 |
38 | RPS6KA4 | 1.28628364 |
39 | BRAF | 1.27825711 |
40 | SYK | 1.27315186 |
41 | ITK | 1.24428989 |
42 | CSF1R | 1.23101608 |
43 | PKN2 | 1.20778402 |
44 | PTK6 | 1.20431300 |
45 | TNK2 | 1.20015699 |
46 | MAP3K10 | 1.18291194 |
47 | MAP3K7 | 1.18087996 |
48 | RIPK4 | 1.17163577 |
49 | EPHA2 | 1.16533906 |
50 | LCK | 1.15308851 |
51 | TEC | 1.14683547 |
52 | JAK2 | 1.11498951 |
53 | NLK | 1.11230284 |
54 | HCK | 1.11050315 |
55 | SIK1 | 1.10740194 |
56 | NEK9 | 1.05840383 |
57 | MST4 | 1.05709520 |
58 | KSR2 | 1.04717446 |
59 | GRK6 | 0.98532779 |
60 | MAP2K3 | 0.91481041 |
61 | MAP3K3 | 0.90719143 |
62 | PIM1 | 0.89535094 |
63 | TTN | 0.86283369 |
64 | MARK3 | 0.83262072 |
65 | LYN | 0.81586179 |
66 | RIPK1 | 0.81059130 |
67 | IRAK1 | 0.72721823 |
68 | ILK | 0.72560608 |
69 | MAP3K8 | 0.69929030 |
70 | EEF2K | 0.69305449 |
71 | MAP2K6 | 0.66604314 |
72 | TESK2 | 0.66305012 |
73 | MST1R | 0.65679790 |
74 | TIE1 | 0.61780791 |
75 | PDK1 | 0.61292147 |
76 | BMX | 0.58996661 |
77 | RAF1 | 0.58791843 |
78 | MAP3K12 | 0.58430112 |
79 | MATK | 0.57482351 |
80 | TGFBR1 | 0.57307941 |
81 | CAMK1D | 0.56304461 |
82 | HIPK2 | 0.55731317 |
83 | MAPK15 | 0.54332959 |
84 | TESK1 | 0.52697972 |
85 | FRK | 0.51996658 |
86 | TRPM7 | 0.51659078 |
87 | GRK7 | 0.49686896 |
88 | FES | 0.49157402 |
89 | LMTK2 | 0.48755703 |
90 | PDPK1 | 0.47635721 |
91 | PRKCQ | 0.47499613 |
92 | PRKCH | 0.46862950 |
93 | PRKG2 | 0.46761498 |
94 | EGFR | 0.46738952 |
95 | SIK3 | 0.46502451 |
96 | MAP3K1 | 0.46292689 |
97 | MAPKAPK2 | 0.45396837 |
98 | ADRBK2 | 0.45174194 |
99 | ABL1 | 0.44369736 |
100 | MAP2K2 | 0.44223066 |
101 | CDC42BPA | 0.43344464 |
102 | PRKCD | 0.42980572 |
103 | MAPK11 | 0.42791091 |
104 | MAPKAPK3 | 0.42699724 |
105 | RPS6KA6 | 0.42480992 |
106 | PAK4 | 0.41512587 |
107 | STK38 | 0.41387304 |
108 | TAOK1 | 0.40192616 |
109 | STK4 | 0.39328102 |
110 | PRPF4B | 0.38901569 |
111 | PRKAA2 | 0.38853152 |
112 | ACVR1B | 0.38062567 |
113 | SCYL2 | 0.37105969 |
114 | PTK2B | 0.36745069 |
115 | KSR1 | 0.36673259 |
116 | PIK3CG | 0.36166974 |
117 | PRKD2 | 0.35783150 |
118 | MAP3K2 | 0.34925317 |
119 | MAP2K1 | 0.33085803 |
120 | CLK1 | 0.32764465 |
121 | SIK2 | 0.31350303 |
122 | CDK6 | 0.31296997 |
123 | IGF1R | 0.31015982 |
124 | MAP3K11 | 0.30485391 |
125 | PASK | 0.29850129 |
126 | MYLK | 0.29730840 |
127 | PDGFRA | 0.29321682 |
128 | INSRR | 0.28732630 |
129 | PTK2 | 0.28209878 |
130 | MUSK | 0.28104341 |
131 | DYRK1B | 0.28066932 |
132 | FER | 0.27555842 |
133 | PDGFRB | 0.27114368 |
134 | FGR | 0.27007301 |
135 | ABL2 | 0.26535232 |
136 | FYN | 0.26381185 |
137 | RPS6KA5 | 0.25837311 |
138 | STK24 | 0.25787481 |
139 | MAP4K2 | 0.22004777 |
140 | GRK1 | 0.21594200 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.00163984 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64699999 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.56466765 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.52690760 |
5 | Measles_Homo sapiens_hsa05162 | 2.38971894 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36880661 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35084703 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28986206 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.20257746 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17198347 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11661962 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.08619881 |
13 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04521588 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04078791 |
15 | Legionellosis_Homo sapiens_hsa05134 | 2.02836466 |
16 | Pertussis_Homo sapiens_hsa05133 | 2.01179187 |
17 | Malaria_Homo sapiens_hsa05144 | 1.92082854 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87368291 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.84819918 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84316575 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.77117865 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74965224 |
23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74561218 |
24 | Lysosome_Homo sapiens_hsa04142 | 1.73474458 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68504596 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.67577045 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63017946 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60289356 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54150295 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48901723 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.41856408 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39708040 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37770294 |
34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.35720527 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33758003 |
36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29904149 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29069290 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.26575228 |
39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24891855 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24621119 |
41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23204418 |
42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21329023 |
43 | Hepatitis C_Homo sapiens_hsa05160 | 1.20307034 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19396112 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.17675378 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 1.16938835 |
47 | Asthma_Homo sapiens_hsa05310 | 1.12282789 |
48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12140623 |
49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11905629 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11721650 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11588803 |
52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09302806 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08478795 |
54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96308674 |
55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95138123 |
56 | Phagosome_Homo sapiens_hsa04145 | 0.91045362 |
57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90257636 |
58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87669180 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86173602 |
60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84730567 |
61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83739054 |
62 | Amoebiasis_Homo sapiens_hsa05146 | 0.82870284 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82513377 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82315954 |
65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79821141 |
66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76062274 |
67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73717939 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.73237129 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.68218809 |
70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67851551 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67393511 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.67351885 |
73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65260468 |
74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64835292 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60179264 |
76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57399638 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55381751 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52177811 |
79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51303414 |
80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50171244 |
81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49423124 |
82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49075310 |
83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48175762 |
84 | Mineral absorption_Homo sapiens_hsa04978 | 0.47357458 |
85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46950151 |
86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46004343 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.44890787 |
88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43096854 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42324509 |
90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42162913 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42065124 |
92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41838864 |
93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40922698 |
94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40894306 |
95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40360803 |
96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39678027 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38716036 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37390918 |
99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37358322 |
100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36509584 |
101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35953796 |
102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35245289 |
103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34567083 |
104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33980926 |
105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33883243 |
106 | Focal adhesion_Homo sapiens_hsa04510 | 0.31505899 |
107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31283108 |
108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30148113 |
109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27659147 |
110 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.26015889 |
111 | Endocytosis_Homo sapiens_hsa04144 | 0.25198921 |
112 | Adherens junction_Homo sapiens_hsa04520 | 0.24192577 |
113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23443202 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23333114 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23324106 |
116 | Bladder cancer_Homo sapiens_hsa05219 | 0.23270839 |
117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22739441 |
118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22529374 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22322358 |
120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22209156 |
121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.21884969 |
122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.21437580 |
123 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20935663 |
124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20627143 |
125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20383229 |
126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.20378301 |
127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18843578 |
128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18537501 |